The importance of early intervention in CHF - Signs and symptom relief

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Effective treatments of congestive heart failure (CHF) must not only reduce mortality, but should also reduce the severity of the signs and symptoms of the syndrome, as these can have a major impact on quality of life. Early intervention can help to make everyday activities easier for patients with CHF and may slow disease progression. This review provides an overview of the efficacies of various therapies in improving the signs and symptoms of CHF, with particular reference to recent data from randomised, double-blind studies of patients receiving the AT1-receptor blocker, candesartan cilexetil.

Original languageEnglish
Pages (from-to)17-23
Number of pages7
JournalJRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Volume1
Issue numberSUPPL. 1
DOIs
StatePublished - Sep 2000
Externally publishedYes

Keywords

  • Angiotensin II type 1-receptor blockers
  • Candesartan cilexetil
  • Congestive heart failure
  • Symptom relief

Fingerprint

Dive into the research topics of 'The importance of early intervention in CHF - Signs and symptom relief'. Together they form a unique fingerprint.

Cite this